JAKARTA (Yosefardi) – PT Bank Mandiri Tbk (BMRI) provides loan for working capital of Rp1 trillion for pharmaceutical firm PT Kalbe Farma Tbk (KLBF).
BMRI also provides Treasury Line facility of US$8 million for KLBF to purchase raw material in dollar denomination or hedging purpose with tenor of one year.
Bank Mandiri has provided Rp2.45 trillion loan for pharmaceutical sector in 2015, grew by 40.80% from Rp1.74 trillion in 2014.
BMRI also provides micro funding (distributor financing) for pharmacy outlets network of PT Enseval Megatrading Tbk located in Bogor, Bekasi, and Jakarta. This loan facility has tenor of 3 years.